Heptares Therapeutics
Shinichiro N. has significant experience in corporate communication and corporate strategy. Shinichiro held the role of Vice President in the IR & Corporate Strategy Department at Sosei Group Corporation starting from June 2018. Prior to that, they were the General Manager of the Corporate Communication Department at JVCKENWOOD Corporation from January 2015 to May 2018. Shinichiro also served as Senior Manager in the Corporate Communications Department at Tokai Tokyo Financial Holdings, Inc. from April 2009 to December 2014.
Shinichiro N. obtained a Bachelor of Arts degree in English Language and Literature from Aoyama Gakuin University from the years 1984 to 1988. Following this, they pursued a Master of Business Administration (MBA) degree specializing in Finance from EU Business School during the years 1992 to 1993.
This person is not in any offices
Heptares Therapeutics
Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, StabilisedReceptors), overcoming a major limiting factor to the development of new drugs targeting this group.